Francesco De Francesco | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Francesco De Francesco | Medicine and Dentistry | Best Researcher Award

Medical Surgeon | Azienda Ospedaliera Universitaria delle Marche | Italy

Dr. Francesco De Francesco is an accomplished clinician-scientist specializing in plastic, reconstructive, and regenerative surgery, with a strong academic background in stem cell biology and tissue engineering. His career reflects a balance of clinical expertise, laboratory research, and teaching, enabling him to translate scientific discoveries into therapeutic innovations. His work has focused extensively on adipose-derived stem cells, extracellular vesicles, and their applications in regenerative medicine, particularly in joint and soft tissue repair. Alongside his research, he has played an important role as a medical executive, advancing clinical practices in reconstructive and hand surgery. He has also contributed to academic training, fostering knowledge transfer and supporting the next generation of medical professionals. Recognized with national scientific qualifications and specialization, his profile reflects leadership, dedication, and significant impact in his field. His measurable research influence is demonstrated through Scopus with 3,218 citations, 122 documents, and an h-index of 30.

Profiles: Scopus | Google Scholar | ORCID

Featured Publications

1.  V. Tirino, V. Desiderio, F. Paino, A. De Rosa, F. Papaccio, M. La Noce, and F. De Francesco, “Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization,” The FASEB Journal, vol. 27, no. 1, pp. 13–24, 2013.

2. V. Tirino, V. Desiderio, R. d’Aquino, F. De Francesco, G. Pirozzi, U. Galderisi, and F. Papaccio, “Detection and characterization of CD133+ cancer stem cells in human solid tumours,” PLoS One, vol. 3, no. 10, p. e3469, 2008.

3. A. Graziano, R. d’Aquino, M. G. C. D. Angelis, F. De Francesco, A. Giordano, and G. Papaccio, “Scaffold’s surface geometry significantly affects human stem cell bone tissue engineering,” Journal of Cellular Physiology, vol. 214, no. 1, pp. 166–172, 2008.

4. F. De Francesco, G. Ricci, F. D’Andrea, G. F. Nicoletti, and G. A. Ferraro, “Human adipose stem cells: from bench to bedside,” Tissue Engineering Part B: Reviews, vol. 21, no. 6, pp. 572–584, 2015.

5. F. De Francesco, V. Tirino, V. Desiderio, G. Ferraro, F. D’Andrea, M. Giuliano, and F. Papaccio, “Human CD34+/CD90+ ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries,” PLoS One, vol. 4, no. 8, p. e6537, 2009.

Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Doctor at Medical University, Varna, Bulgaria

Dr. Yoana Dyankova Dyankova is a dedicated pediatrician and clinical researcher specializing in pediatric gastroenterology, hepatology, and nutrition. She holds a PhD in Pediatrics from the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, where she also serves in the Pediatric Intensive Care Unit at St. Marina University Hospital. Her research focuses primarily on celiac disease in children, particularly its impact on bone health, as demonstrated in her dissertation and multiple peer-reviewed publications, including a recent article in Nutrients (2025). Dr. Dyankova is an active member of national pediatric and gastroenterology associations and contributes to both clinical care and academic development. Fluent in English and German, she engages with the international scientific community and remains committed to translating research into improved patient outcomes. With her growing publication record, clinical integration, and academic rigor, she stands out as a promising young researcher in the field of pediatric medicine.

Professional Profile 

Google Scholar
ORCID Profile 

Education

Dr. Yoana Dyankova Dyankova began her academic journey at the Vasil Drumev High School of Natural Sciences and Mathematics in Veliko Tarnovo, graduating in 2010. She pursued her medical degree at the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, completing it in 2016. From 2017 to 2022, she specialized in pediatrics, gaining comprehensive clinical training and board certification in the field. In 2018, she enrolled in a PhD program in Pediatrics at the same university, where she focused her research on celiac disease and its effects on pediatric bone health. She successfully defended her dissertation in 2023. Dr. Dyankova has since continued to develop professionally by pursuing further specialization in pediatric gastroenterology starting in July 2025. Her academic path demonstrates strong commitment, discipline, and a focused interest in improving pediatric healthcare through both clinical practice and rigorous scientific research.

Professional Experience

Dr. Dyankova has cultivated a balanced career combining clinical excellence and academic growth. Since January 2022, she has served as a pediatrician at the Pediatric Intensive Care Unit (PICU) of the First Children’s Clinic, St. Marina University Hospital in Varna. Her role in the PICU places her at the frontline of managing critically ill children, often requiring advanced decision-making and teamwork in high-pressure situations. Prior to this, she completed a five-year pediatric residency, gaining hands-on experience in general pediatrics. Her transition into the subspecialty of pediatric gastroenterology as of July 2025 marks a strategic shift aligned with her research interests. Parallel to her clinical duties, Dr. Dyankova was engaged in doctoral studies for five years, conducting original research and contributing to academic publications. Her dual role as both a clinician and researcher enhances her ability to apply scientific findings directly to patient care, making her a valuable asset in modern pediatric medicine.

Research Interest

Dr. Dyankova’s primary research interests lie at the intersection of pediatric gastroenterology, hepatology, and nutrition, with a concentrated focus on celiac disease (CD). Her doctoral thesis explored bone health in children with CD, addressing the metabolic and developmental complications arising from malabsorption and chronic inflammation. Beyond celiac disease, she has expressed research interest in related gastrointestinal disorders such as inflammatory bowel disease (IBD), as well as broader issues within pediatric intensive care. Her work is characterized by clinical relevance and translational value, aiming to bridge the gap between scientific research and bedside care. Publications in both national and international journals reflect her dedication to improving diagnostic and treatment protocols in children with chronic gastrointestinal conditions. Dr. Dyankova continues to build her research portfolio by participating in collaborative studies, focusing on early diagnosis, nutritional interventions, and long-term management outcomes in affected pediatric populations, ensuring a direct impact on clinical practice.

Award and Honor

While specific named awards are not listed in the biography, Dr. Yoana Dyankova Dyankova has received notable academic and professional recognition through her successful completion of a PhD and multiple scientific publications. Her research has been published in reputable journals such as Nutrients, indicating peer validation and relevance of her work. She is an active member of the National Pediatric Association and the community of Pediatric Gastroenterologists in Bulgaria, reflecting her standing in the professional community. These memberships signify not only recognition by peers but also her continued contribution to scientific discussions and advancements in pediatric healthcare. Her role in high-stakes clinical environments like the Pediatric Intensive Care Unit further demonstrates trust in her medical competence and decision-making. With growing academic output and clear specialization in a crucial field, Dr. Dyankova is well-positioned to earn future distinctions and leadership roles in pediatric research and clinical practice at both national and international levels.

Conclusion

Dr. Yoana Dyankova Dyankova exemplifies the qualities of a dedicated clinician-scientist, balancing hands-on pediatric care with high-impact academic research. With a solid foundation in pediatrics and a focused interest in gastroenterology and nutrition, she has steadily advanced her career through both clinical excellence and scholarly contribution. Her doctoral work on bone health in children with celiac disease highlights her ability to address complex, real-world health challenges through evidence-based research. Now working in a pediatric intensive care setting and continuing her subspecialty training, Dr. Dyankova is expanding her expertise and influence in critical areas of child health. Her publications, professional affiliations, and academic achievements underscore a deep commitment to the advancement of pediatric medicine. While still early in her career, her trajectory suggests strong potential for leadership in research and healthcare. She is a promising candidate for recognition such as the Best Researcher Award and is well-poised for continued professional impact.

Publications Top Notes

  1. Title: Presentation of Childhood Newly-Diagnosed Diabetes During the COVID-19 Pandemic – Is There a Change?

    • Authors: Y. Bazdarska, V. Iotova, T. Karamfilova, Y. Dyankova, T. Stefanova, …

    • Journal: Diabetes Technology & Therapeutics, Vol. 23, A202

    • Year: 2021

  1. Title: Delayed Bone Age and Osteoprotegerin Levels in Pediatric Celiac Disease: A Three-Year Case–Control Study

    • Authors: R. Pancheva, Y. Dyankova, N. Rasheva, K. Koleva, V. Iotova, M. Dzhogova, M. Fiore, M. Georgieva

    • Journal: Nutrients, Vol. 17 (14), Article 2295

    • Year: 2025

  1. Title: Macrophage Activation Syndrome After COVID-19 Infection in a Patient with Systemic Juvenile Idiopathic Arthritis

    • Authors: M. Boyadzhiev, B. Varbanova, M. Belcheva, P. Shivachev, D. Krumova, Y. Dyankova, …

    • Journal: Scripta Scientifica Medica, Vol. 55(1), pp. 27–31

    • Year: 2023

  1. Title: Bone Health in Children with Celiac Disease (PhD Dissertation)

    • Author: Y. Dyankova

    • Database: PQDT-Global (ProQuest Dissertations)

    • Year: 2022

  1. Title: New Developments in the Diagnostics of Celiac Disease in Children

    • Authors: Y. Dyankova, M. Georgieva, N. Rasheva, K. Koleva

    • Journal: Journal of the Union of Scientists-Varna. Medicine and Ecology Series, Vol. 24(1)

    • Year: 2019

  1. Title: Bacterial Pulmonary Colonization with Pseudomonas aeruginosa in Cystic Fibrosis Patients

    • Authors: M. Nikolova, Y. Dyankova, I. Hristov, M. Georgieva

    • Journal: Izvestia Journal of the Union of Scientists-Varna. Medicine and Ecology Series

    • Year: 2019

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Professor at IDIVAL, Spain

Professor Javier Crespo is a distinguished physician-scientist and academic leader in the field of digestive and liver diseases. Currently a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL, he has made significant contributions through over 400 original publications, more than 120 clinical trials, and leadership in numerous national and international research projects. With an H-index of 70 and over 30,000 citations, his work has had a profound global impact. He has played a pivotal role in national health strategies, including Spain’s Hepatitis C elimination plan, and served as President of major professional societies such as SEPD. A mentor to numerous doctoral and master’s students, he has also received multiple prestigious awards for his contributions to medicine and research. His leadership at Marqués de Valdecilla University Hospital earned repeated national recognition for excellence in digestive and hepatitis care.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Professor Javier Crespo earned his Degree in Medicine and General Surgery from the University of Cantabria with an Outstanding qualification. He later obtained his Doctorate in Medicine in 1993, receiving the Extraordinary Doctorate Award for academic excellence. His formal education laid a strong foundation for a career marked by clinical rigor and academic depth. In addition to his medical qualifications, he has been accredited as a Professor by ANECA (the Spanish National Agency for Quality Assessment and Accreditation). His academic journey reflects not only excellence in performance but also an enduring commitment to scientific learning and advancement. His scholarly trajectory is rooted in a lifelong dedication to the field of hepatology and digestive pathology, with an early focus on merging basic medical science with clinical research. These formative years have played a crucial role in shaping his influential career in medicine, teaching, and research.

Professional Experience

Professor Crespo has held several prestigious positions throughout his career. He is a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL. He served as Head of the Digestive Service at Marqués de Valdecilla University Hospital from 2010 to 2024. Additionally, he has played strategic roles in healthcare governance, including being a member of Spain’s National Strategic Plan against Hepatitis C since 2015 and coordinator of the AEEH National Liver Health Plan Challenge 2032. His leadership extends to professional societies—he served as President of the Spanish Society of Digestive Pathology (SEPD), President of the National Digestive Commission, and Secretary of the Spanish Association for the Study of the Liver. His professional career reflects a unique blend of clinical excellence, policy leadership, academic mentoring, and research management, making him one of the most respected figures in his specialty.

Research Interest

Professor Crespo’s primary research interests center around digestive and liver diseases, with a particular focus on hepatitis C, liver cirrhosis, and inflammatory bowel diseases. He has led more than 120 clinical trials across Phases I–III and participated in 15 national and 8 international competitive research projects. His translational approach bridges laboratory findings with clinical application, especially in hepatology. Under his leadership, the IDIVAL research group has produced high-impact findings in digestive pathology and liver disease progression. He has authored over 400 original scientific articles, with a strong presence in high-impact journals. His work is cited more than 30,000 times, and he holds an H-index of 70, underscoring his global influence. He is also actively involved in supervising doctoral and postgraduate theses, reflecting his dedication to advancing the next generation of researchers in gastroenterology. His research has contributed significantly to public health, particularly in the management and elimination of hepatitis C.

Award and Honor

Professor Javier Crespo has received numerous national and international awards that recognize both his scientific excellence and public health impact. Among his most prestigious accolades are the Elimination Champions 2023 International Award, granted by the Coalition for Global Hepatitis Elimination, and the International Award at the VI LIFE Forum for HCV Elimination in Lima (2024). Nationally, he has been honored with the Commendation of the Civil Order of Health, the SEPD Gold Medal, and the ACAD Gold Medal. He was also named an Illustrious Torrelaveguense in 2024. Under his leadership, the Digestive Service at Marqués de Valdecilla University Hospital received the Best in Class Award for several consecutive years for excellence in digestive and hepatitis care. His honors reflect not only scientific merit but also his dedication to clinical service and public health leadership, making him one of the most decorated professionals in his field.

Conclusion

In conclusion, Professor Javier Crespo is a highly accomplished and impactful leader in the fields of gastroenterology and hepatology. His career combines outstanding academic achievement, clinical leadership, and translational research excellence. With more than 30,000 citations and an H-index of 70, his scientific contributions have shaped current practices in liver disease treatment and public health strategies. He has held top-level positions in hospitals, universities, research institutes, and national health commissions, evidencing his multifaceted influence. Through his mentorship, he has cultivated a generation of researchers and clinicians, further extending his legacy. His work has not only garnered national and international recognition through prestigious awards but has also led to meaningful improvements in patient care, especially in hepatitis C management. Professor Crespo exemplifies the qualities of a visionary researcher, a compassionate physician, and a dedicated educator—making him exceptionally worthy of recognition such as the Best Researcher Award.

Publications Top Notes

  • Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis

    • Authors: Not listed

    • Year: 2025

    • Citations: 3

  • Letter to the Editor: Optimizing MASLD treatment—A “lead-in phase” before resmetirom

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • Comprehensive Diagnosis of Viral Hepatitis in Spain: Bases for Implementation

    • Authors: Not listed

    • Year: 2025

  • Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    • Authors: ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, …

    • Year: 2023

    • Citations: 4,096

  • Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn’s disease

    • Authors: N Inohara, Y Ogura, A Fontalba, O Gutierrez, F Pons, J Crespo, K Fukase, …

    • Year: 2003

    • Citations: 2,245

  • Modeling NAFLD disease burden in 8 countries (2016–2030)

    • Authors: C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, …

    • Year: 2018

    • Citations: 2,027

  • A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    • Authors: HSA Newsome, PN Buchholtz, K Cusi, M Linder, T Okanoue, V Ratziu, S Sanyal, …

    • Year: 2021

    • Citations: 1,673

  • Obeticholic acid for the treatment of NASH: Phase 3 trial analysis

    • Authors: ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, …

    • Year: 2019

    • Citations: 1,286

  • Elafibranor resolves NASH without fibrosis worsening

    • Authors: SA Ratziu, V Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, …

    • Year: 2016

    • Citations: 1,217

  • Sofosbuvir and ribavirin in HCV genotypes 2 and 3

    • Authors: ER Zeuzem, S Dusheiko, GM Salupere, R Mangia, A Flisiak, RH Hyland, …

    • Year: 2014

    • Citations: 1,048

  • A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

    • Authors: Not listed

    • Year: 2024

    • Citations: 983

  • Gene expression of TNF-α and TNF receptors in NASH patients

    • Authors: J Crespo, A Cayón, P Fernández‐Gil, M Hernández‐Guerra, M Mayorga, …

    • Year: 2001

    • Citations: 971

  • Advancing the global public health agenda for NAFLD: Consensus statement

    • Authors: JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, …

    • Year: 2022

    • Citations: 683

Daniel Akyeampong | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Daniel Akyeampong | Medicine and Dentistry | Best Researcher Award

General Surgery Resident at Medical University of South Carolina, United States

Dr. Daniel K. Akyeampong, MD, born on August 13, 1993, is an emerging leader in the field of general surgery and medical education. Currently a resident in General Surgery at the Medical University of South Carolina, he has demonstrated a profound commitment to both clinical practice and academic achievement. He holds dual roles as a mentor and educator, fostering future physicians while simultaneously contributing to advancements in surgical care. A natural communicator, Daniel excels in patient-centered care and effective communication, which has earned him multiple recognitions, including the Trauma Llama Award in 2025. His dedication to the medical field is complemented by his active involvement in various professional societies such as the American College of Surgeons and the Eastern Association for the Surgery of Trauma. With a focus on both clinical excellence and research, Daniel is poised to make significant contributions to the medical community in the years to come.

Education

Daniel K. Akyeampong’s educational journey reflects a deep commitment to academic excellence and medical innovation. He earned his Bachelor of Science degree from Virginia Commonwealth University in 2015, graduating cum laude. Following his undergraduate studies, Daniel pursued his Doctor of Medicine (MD) at the University of Virginia School of Medicine, completing his degree in 2021. His rigorous academic training was followed by an internship at Vanderbilt University in General Surgery, before he embarked on his residency at the Medical University of South Carolina. Throughout his education, Daniel consistently demonstrated a passion for both learning and teaching, as evidenced by his involvement in multiple teaching and mentorship roles. His academic achievements are further underscored by prestigious awards, including the Bowman Scholar award and numerous merit scholarships, which highlight his academic dedication and promise as a future leader in the medical field.

Professional Experience

Daniel K. Akyeampong has accumulated valuable professional experience in both clinical practice and academic settings. His clinical journey began during his internship in General Surgery at Vanderbilt University, where he honed his surgical skills and deepened his understanding of patient care. In 2022, Daniel began his residency at the Medical University of South Carolina, continuing to develop his expertise in general surgery. He has actively participated in various trauma and surgical care initiatives, where his communication and patient-centered approach have earned him recognition. Additionally, Daniel’s leadership abilities extend beyond patient care, as he has taken on roles such as Administrative Chief Resident for 2025. His involvement in various committees, including the James Ramsay Surgical History Society and the Medical Society of Virginia, highlights his commitment to advancing the profession through service and leadership. Daniel’s experience as a Nationally Certified Pharmacy Technician also adds to his comprehensive understanding of healthcare systems, further enhancing his capability as a surgeon and educator.

Research Interests

Dr. Daniel Akyeampong’s research interests primarily focus on the intersection of surgery, trauma care, and medical education. He has a keen interest in exploring clinical and surgical innovations that enhance patient outcomes, particularly in trauma and emergency surgical settings. Daniel’s research has already been acknowledged with a Larry S. Nichter Research Award finalist recognition, which highlights his potential for making significant contributions to the field. He is particularly driven by the need for advancements in surgical techniques and protocols that improve patient survival rates in trauma situations. In addition to his clinical research interests, Daniel is dedicated to the advancement of medical education, focusing on improving teaching methods and mentorship in surgical training. His interest in education is evident in his multiple awards for teaching excellence and his active involvement in mentoring medical students and residents. By combining clinical expertise with research, Daniel seeks to contribute to both practical improvements in patient care and the academic growth of future surgeons.

Awards and Honors

Throughout his medical career, Dr. Daniel Akyeampong has received numerous awards and honors that reflect his dedication, excellence, and leadership within the medical community. Notable among these is the Trauma Llama Award (2025), recognizing his exceptional communication and patient-centered care during pediatric trauma activations. Additionally, Daniel has earned the Resident Award for Excellence in Student Teaching (2023, 2024), which highlights his outstanding contributions to medical education and his role in mentoring medical students. He has also been nominated for the prestigious Golden Apple Excellence in Teaching Award in 2023 and 2024, an honor given to faculty members nominated by students for excellence in teaching. As a finalist for the Larry S. Nichter Research Award in 2021, Daniel has demonstrated his commitment to impactful research in the medical field. His academic excellence is further underscored by several merit-based scholarships, such as the Bowman Scholar award and the Society of the Cincinnati Scholarship. These awards serve as a testament to his potential for continued success in both academic and clinical medicine.

Conclusion

Daniel K. Akyeampong shows strong potential for the Best Researcher Award, particularly through his combination of academic excellence, clinical expertise, and leadership. His research contributions, while recognized, could be enhanced by a more robust publication record and broader scope of research. With more focus on these areas, he has the potential to become a leading figure in surgical and clinical research.

Publications Top Notes

  • Epidemiology of Symptomatic Non-Union/Malunion Rib Fractures

    • Author: Daniel Akyeampong, Alexander Hoey, Ronald Gross, Evert Eriksson

    • Year: 2025

    • Citation: Akyeampong D, Hoey A, Gross R, Eriksson E. Epidemiology of Symptomatic Non-Union/Malunion Rib Fractures. Surgeries. 2025 Apr; 6(2):32. DOI: 10.3390/surgeries6020032

  • Anatomy of the Interchondral Joints and the Effects on Mobility of Ribs

    • Author: Daniel Akyeampong, Alexander Hoey, Aakash Patel, Andrew Privette, William Ganske, Justin Halmark, Christopher Muir, Steven Kubalak, Evert Eriksson

    • Year: 2024

    • Citation: Akyeampong D, Hoey A, Patel A, Privette AR, Ganske W, Halmark J, Muir C, Kubalak SW, Eriksson EA. Anatomy of the Interchondral Joints and the Effects on Mobility of Ribs. The Journal of Trauma and Acute Care Surgery. 2024 Sep 6; DOI: 10.1097/ta.0000000000004430

  • Racial and Gender Discrimination in Hand Surgery Letters of Recommendation

    • Author: Bradford PS, Daniel Akyeampong, MA 2nd Fleming, Andrew Dacus, AB Chhabra, DEGEORGE BRENT

    • Year: 2021

    • Citation: Bradford PS, Akyeampong D, Fleming MA 2nd, Dacus AR, Chhabra AB, DeGeorge B. Racial and Gender Discrimination in Hand Surgery Letters of Recommendation. The Journal of Hand Surgery. 2021 Aug 20; DOI: 10.1016/j.jhsa.2021.07.009

  • Three-dimensional Printing and Craniosynostosis Surgery

    • Author: Soldozy S, K. Yağmurlu, Daniel K. Akyeampong, Richard Burke, PF Morgenstern, RF Keating, JS Black, JA Jane Jr, HR Syed

    • Year: 2021

    • Citation: Soldozy S, Yağmurlu K, Akyeampong DK, Burke R, Morgenstern PF, Keating RF, Black JS, Jane JA Jr, Syed HR. Three-dimensional Printing and Craniosynostosis Surgery. Child’s Nervous System. 2021 Mar 29; DOI: 10.1007/s00381-021-05133-8

  • Systematic Review of Functional Mapping and Cortical Reorganization in the Setting of Arteriovenous Malformations, Redefining Anatomical Eloquence

    • Author: Soldozy S, Daniel K. Akyeampong, DL Barquin, Pedro Norat, Kaan Yağmurlu, JD Sokolowski, KA Sharifi, P Tvrdik, MS Park, MYS Kalani

    • Year: 2020

    • Citation: Soldozy S, Akyeampong DK, Barquin DL, Norat P, Yagmurlu K, Sokolowski JD, Sharifi KA, Tvrdik P, Park MS, Kalani MYS. Systematic Review of Functional Mapping and Cortical Reorganization in the Setting of Arteriovenous Malformations, Redefining Anatomical Eloquence. Frontiers in Surgery. 2020 Sep 30; DOI: 10.3389/fsurg.2020.514247

  • Consequences of Chronic Frequent Premature Atrial Contractions: Association with Cardiac Arrhythmias and Cardiac Structural Changes

    • Author: Sampath Gunda, Daniel Akyeampong, J. Gomez-Arroyo, Daniel G. Jovin, Gurukripa Narayan Kowlgi, Karoly Kaszala, Tan AY, JN Koneru, Jordana Kron, KA Ellenbogen et al.

    • Year: 2019

    • Citation: Gunda S, Akyeampong D, Gomez-Arroyo J, Jovin DG, Kowlgi GN, Kaszala K, Tan AY, Koneru JN, Kron J, Ellenbogen KA. Consequences of Chronic Frequent Premature Atrial Contractions: Association with Cardiac Arrhythmias and Cardiac Structural Changes. Journal of Cardiovascular Electrophysiology. 2019 Aug 1; DOI: 10.1111/jce.14067

 

Syeda Hossain | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Assoc. Prof. Dr. Syeda Hossain | Medicine and Dentistry | Best Researcher Award

Associate Professor at University of Sydney, Australia

Associate Professor Dr. Syeda Zakia Hossain is a distinguished health sociologist and demographer with over 25 years of experience in higher education. She currently serves as an Associate Professor in the Faculty of Medicine and Health at the University of Sydney, Australia. Dr. Hossain earned her PhD in Sociology from the University of Queensland in 1994, following a Master’s in Demography with Distinction from the Australian National University in 1986, and a Master’s in Sociology from the University of Dhaka, Bangladesh, where she graduated First Class First. Her interdisciplinary research focuses on health disparities, aging populations, women’s health, and social determinants of health, particularly within culturally and linguistically diverse communities. Dr. Hossain has held various leadership roles, including Course Director for the Bachelor of Health Sciences and Coordinator for the Bachelor of Science (Health) program. Her dedication to academia has been recognized through several awards, such as the Vice-Chancellor CALD Women’s Sponsorship Program Award from the University of Sydney in 2018. Beyond her academic commitments, she serves as an Executive Editor of the Journal of Community Medicine and Health Education and is an Executive Member of RAPID, a research and policy integration organization in Bangladesh.

Professional Profile

Education

Associate Professor Dr. Syeda Zakia Hossain has an extensive academic background in sociology, demography, and public health. She earned her PhD in Sociology from the University of Queensland, Australia, in 1994, focusing on social determinants of health and population studies. Prior to that, she completed a Master’s in Demography with Distinction from the Australian National University in 1986, further strengthening her expertise in population health and statistical analysis. Dr. Hossain began her higher education journey at the University of Dhaka, Bangladesh, where she obtained a Master’s degree in Sociology, achieving First Class First honors. Her early academic excellence laid the foundation for her future research and teaching in health sociology and demography. Throughout her career, she has combined her interdisciplinary education with real-world applications, contributing significantly to research on aging populations, women’s health, and culturally diverse healthcare needs. Her education has not only shaped her research focus but has also positioned her as a leading academic in the fields of health sciences and social policy. Dr. Hossain’s strong educational background continues to influence her teaching, mentorship, and contributions to global health research and policy initiatives.

Professional Experience

Associate Professor Dr. Syeda Zakia Hossain has over 25 years of professional experience in academia, research, and leadership roles in public health and sociology. She is currently an Associate Professor in the Faculty of Medicine and Health at the University of Sydney, Australia, where she has been actively involved in teaching, research, and curriculum development. Dr. Hossain has held key academic positions, including Course Director for the Bachelor of Health Sciences and Coordinator for the Bachelor of Science (Health) program. Her research expertise spans health disparities, aging populations, women’s health, and social determinants of health, particularly within culturally and linguistically diverse communities. She has worked on numerous research projects addressing global health challenges and has collaborated with national and international institutions. Dr. Hossain is also an Executive Editor of the Journal of Community Medicine and Health Education and serves as an Executive Member of RAPID, a research and policy organization in Bangladesh. Her contributions to academia have been recognized through prestigious awards, including the Vice-Chancellor CALD Women’s Sponsorship Program Award from the University of Sydney. Through her extensive professional experience, Dr. Hossain continues to influence health policies, mentor future scholars, and advance research in health sociology and demography.

Research Interests

Associate Professor Dr. Syeda Zakia Hossain’s research interests lie at the intersection of health sociology, demography, and public health, with a particular focus on health disparities, aging populations, and women’s health. She explores the social determinants of health and their impact on culturally and linguistically diverse (CALD) communities, aiming to address healthcare inequities across different demographic groups. Her research delves into aging and elderly care, examining the challenges faced by older adults, including social isolation, mental health issues, and access to healthcare services. Women’s health is another key area of her work, where she investigates maternal health, reproductive rights, and gender-based health disparities. Dr. Hossain is also actively engaged in studying migration and health, particularly how immigrant communities adapt to healthcare systems in their host countries. Her interdisciplinary research combines qualitative and quantitative methods to develop evidence-based policies that promote health equity. Through her collaborations with national and international institutions, she contributes to research that informs policy decisions and enhances healthcare systems worldwide. Dr. Hossain’s commitment to addressing global health challenges continues to shape her scholarly work, making significant contributions to the fields of public health, sociology, and demography.

Awards and Honors

Associate Professor Dr. Syeda Zakia Hossain has received several prestigious awards and honors in recognition of her contributions to academia, research, and public health. Among her notable achievements, she was awarded the Vice-Chancellor CALD Women’s Sponsorship Program Award from the University of Sydney in 2018, acknowledging her leadership and commitment to promoting diversity and inclusion in higher education. Her research excellence and dedication to addressing health disparities have also earned her recognition at national and international levels. As an esteemed scholar, she has been invited to contribute to global health discussions, policy development, and academic collaborations. Dr. Hossain’s influential work in health sociology and demography has positioned her as a key figure in public health research, particularly in areas related to aging populations, women’s health, and social determinants of health. In addition to academic accolades, she serves as an Executive Editor for the Journal of Community Medicine and Health Education and holds a leadership role in RAPID, a research and policy integration organization in Bangladesh. Her numerous honors and awards reflect her outstanding contributions to academia, research, and policy-making, further establishing her as a leading expert in the field of health and social sciences.

Conclusion

Associate Professor Syeda Zakia Hossain is a highly accomplished academic, researcher, and educator with a distinguished career spanning over three decades. Her extensive expertise in sociology, demography, and public health has led to significant contributions in research, teaching, and policy development. Through her leadership roles at the University of Sydney, she has influenced curriculum development, student mentorship, and interdisciplinary collaborations. Her research, particularly in women’s health, migrant health, and social determinants of health, has had a meaningful impact on public health awareness and policy. With numerous research collaborations, international partnerships, and active participation in advisory committees, she continues to shape the academic and healthcare landscape. While expanding her research funding and interdisciplinary collaborations could further strengthen her impact, her dedication to education, social well-being, and public health is commendable. Overall, her career reflects a strong commitment to academic excellence, research innovation, and improving global health outcomes.

Publications Top Noted

  • Title: Rumour and social stigma as barriers to the prevention of coronavirus disease (COVID-19): What solutions to consider?
    • Authors: MN Huda, R Islam, MO Qureshi, S Pillai, SZ Hossain
    • Year: 2020
    • Citations: 29
    • Source: Global Biosecurity 2
  • Title: Gendered perspectives on climate change adaptation: a quest for social sustainability in Badlagaree village, Bangladesh
    • Authors: MA Hossen, D Benson, SZ Hossain, Z Sultana, MM Rahman
    • Year: 2021
    • Citations: 28
    • Source: Water 13 (14), 1922
  • Title: Breast cancer knowledge and participation in breast screening practices among Southeast Asian women living in Sydney
    • Authors: SZ Hossain, L Robinson, J Clarke
    • Year: 2016
    • Citations: 24
    • Source: GSTF Journal of Nursing and Health Care (JNHC) 3 (2)
  • Title: Understanding smoking behaviour among secondary school students in Amman, Jordan: a qualitative study
    • Authors: HM Shadid, SZ Hossain
    • Year: 2013
    • Citations: 23
    • Source: J Community Med Health Educ 3 (2), 199
  • Title: Functional analysis of HIV/AIDS stigma: Consensus or divergence?
    • Authors: H Hosseinzadeh, SZ Hossain
    • Year: 2011
    • Citations: 22
    • Source: Health Education & Behavior 38 (6), 584-595
  • Title: Decision making, use of contraception and fertility in Bangladesh: A path analysis
    • Authors: S Zakia Hossain
    • Year: 1998
    • Citations: 18
    • Source: International Journal of Sociology and Social Policy 18 (7/8), 27-55
  • Title: Women’s breast cancer knowledge and health communication in the United Arab Emirates
    • Authors: D Abu Awwad, SZ Hossain, M Mackey, P Brennan, S Adam
    • Year: 2020
    • Citations: 17
    • Source: Healthcare 8 (4), 495
  • Title: Confidence to manage menstruation among university students in Australia: evidence from a cross-sectional survey
    • Authors: AK Munro, M Keep, EC Hunter, SZ Hossain
    • Year: 2022
    • Citations: 15
    • Source: Women’s Health 18, 17455065211070666
  • Title: Comparative analysis of breast cancer incidence rates between Australia and Japan: screening target implications
    • Authors: MM Mizukoshi, SZ Hossain, A Poulos
    • Year: 2020
    • Citations: 15
    • Source: Asian Pacific Journal of Cancer Prevention: APJCP 21 (7), 2123
  • Title: Preliminary investigation of mammographic density among women in Riyadh: association with breast cancer risk factors and implications for screening practices
    • Authors: SM Albeshan, SZ Hossain, MG Mackey, JK Peat, FM Al Tahan, …
    • Year: 2019
    • Citations: 15
    • Source: Clinical Imaging 54, 138-147
  • Title: Smoking behaviour, knowledge and perceived susceptibility to lung cancer among secondary-school students in Amman, Jordan
    • Authors: HM Shadid, SZ Hossain
    • Year: 2015
    • Citations: 15
    • Source: East Mediterr Health J 21 (3), 185-93
  • Title: Collaborative practice in early childhood intervention from the perspectives of service providers
    • Authors: CH Yang, SZ Hossain, G Sitharthan
    • Year: 2013
    • Citations: 15
    • Source: Infants & Young Children 26 (1), 57-73
  • Title: Medical waste management-related factors affecting health and experiences of health risks among medical waste handlers in low and middle-income countries: a systematic review
    • Authors: MN Huda, TG Hailemariam, SZ Hossain, JS Malo, S Khan, …
    • Year: 2022
    • Citations: 14
    • Source: BMJ Open 12 (3), e056037
  • Title: The involvement of Bangladeshi girls and women in sex work: sex trafficking, victimhood, and agency
    • Authors: MN Huda, SZ Hossain, TM Dune, ASM Amanullah, A Renzaho
    • Year: 2022
    • Citations: 14
    • Source: International Journal of Environmental Research and Public Health 19 (12), 7458
  • Title: Mammographic breast density of Japanese women living in Australia: implications for breast screening policy
    • Authors: MM Mizukoshi, SZ Hossain, A Poulos
    • Year: 2019
    • Citations: 14
    • Source: Asian Pacific Journal of Cancer Prevention: APJCP 20 (9), 2811
  • Title: An exploratory study of acculturation among Muslims in Australia
    • Authors: M Abbas, G Sitharthan, MJ Hough, SZ Hossain
    • Year: 2018
    • Citations: 14
    • Source: Social Identities 24 (6), 764-778
  • Title: Migrant and refugee youth perspectives on sexual and reproductive health and rights in Australia: a systematic review
    • Authors: S Napier-Raman, SZ Hossain, MJ Lee, E Mpofu, P Liamputtong, T Dune
    • Year: 2022
    • Citations: 10
    • Source: Sexual Health 20 (1), 35-48
  • Title: Mammographic density distribution in Ras Al Khaimah (RAK): relationships with demographic and reproductive factors
  • Authors: SM Albeshan, SZ Hossain, MG Mackey, D Demchig, JK Peat, PC Brennan
  • Year: 2018
  • Citations: 10
  • Source: Asian Pacific Journal of Cancer Prevention: APJCP 19 (6), 1607
  • Title: Can breast self-examination and clinical breast examination along with increasing breast awareness facilitate earlier detection of breast cancer in populations with advanced …
    • Authors: SM Albeshan, SZ Hossain, MG Mackey, PC Brennan
    • Year: 2020
    • Citations: 107
    • Source: Clinical Breast Cancer 20 (3), 194-200
  • Title: A systematic review of the menstrual experiences of university students and the impacts on their education: a global perspective
    • Authors: AK Munro, EC Hunter, SZ Hossain, M Keep
    • Year: 2021
    • Citations: 97
    • Source: PloS One 16 (9), e0257333
  • Title: Knowledge, attitude and practice around breast cancer and mammography screening among Jordanian women
    • Authors: DS Al-Mousa, M Alakhras, SZ Hossain, AG Al-Sa’di, M Al Hasan, …
    • Year: 2020
    • Citations: 71
    • Source: Breast Cancer: Targets and Therapy, 231-242
  • Title: Breast cancer epidemiology in Gulf Cooperation Council countries: a regional and international comparison
    • Authors: SM Albeshan, MG Mackey, SZ Hossain, AA Alfuraih, PC Brennan
    • Year: 2018
    • Citations: 70
    • Source: Clinical Breast Cancer 18 (3), e381-e392
  • Title: The role of acculturation in health status and utilization of health services among the Iranian elderly in metropolitan Sydney
    • Authors: M Alizadeh-Khoei, RM Mathews, SZ Hossain
    • Year: 2011
    • Citations: 58
    • Source: Journal of Cross-Cultural Gerontology 26, 397-405
  • Title: Elder abuse: risk factors of abuse in elderly community-dwelling Iranians
    • Authors: M Alizadeh-Khoei, F Sharifi, SZ Hossain, H Fakhrzadeh, Z Salimi
    • Year: 2014
    • Citations: 49
    • Source: Educational Gerontology 40 (7), 543-554
  • Title: Prevalence and risk factors of erectile dysfunction among patients attending primary health care centres in Qatar
    • Authors: A Ahmed, A Alnaama, K Shams, M Salem
    • Year: 2011
    • Citations: 35
    • Source: East Mediterr Health J 17 (7), 587-92
  • Title: Translational strategies to control and prevent spread of COVID-19 in the Rohingya refugee camps in Bangladesh
    • Authors: AHM Kamal, MN Huda, CA Dell, SZ Hossain, SS Ahmed
    • Year: 2020
    • Citations: 34
    • Source: Global Biosecurity 2
  • Title: Perceived stigma and social risk of HIV testing and disclosure among Iranian-Australians living in the Sydney metropolitan area
    • Authors: H Hosseinzadeh, SZ Hossain, S Bazargan-Hejazi
    • Year: 2011
    • Citations: 33
    • Source: Sexual Health 9 (2), 171-177
  • Title: Identity construction of second-generation Iranians in Australia: Influences and perspectives
    • Authors: M Asghari-Fard, SZ Hossain
    • Year: 2017
    • Citations: 30
    • Source: Social Identities 23 (2), 126-145

 

Raquel Conceicao | Biomedical Engineering | Best Researcher Award

Published on by World Top Scientists

Prof. Raquel Conceicao | Biomedical Engineering | Best Researcher Award

Assistant professor with habilitation, Institute of Biomedical Engineering and Biophysics, Faculty of Sciences, University of Lisbon, Portugal

🌟 Raquel Conceição is an award-winning assistant professor and researcher with habilitation at the University of Lisbon, Portugal. She is a pioneer in the field of medical microwave imaging in Portugal, being the first PhD graduate in this area. Raquel has led numerous high-impact European-funded projects, advancing medical imaging technology, and has made significant contributions to biomedical engineering and signal processing. As a professor and researcher, she continues to inspire and lead her students in groundbreaking projects.

Publication Profile

Google Scholar

Education

🎓 Raquel holds a PhD in Electrical & Electronic Engineering from the National University of Ireland Galway (2011) and an Integrated Master’s in Biomedical Engineering from the NOVA University of Lisbon (2007). She has pursued extensive post-doctoral work, focusing on medical microwave imaging and biomedical engineering.

Experience

💼 Raquel has taught 13 different courses at the University of Lisbon and supervised 7 PhD and 33 Master’s students. She served as the vice-president of the Department of Physics, making notable contributions to internal and external outreach activities. She was also the vice-coordinator and coordinator of the Master’s in Biomedical Engineering and Biophysics programs, where she played a key leadership role.

Research Focus

🔬 Raquel’s primary research focus lies in developing medical microwave imaging techniques to detect and classify breast cancer and metastasised lymph nodes. Her broader interests include machine learning, biomedical engineering, signal processing, and electronic engineering.

Awards and Honours

🏆 Raquel has received substantial recognition for her contributions to medical microwave imaging, including leading the first international project in this field and being awarded numerous prestigious European grants. She has attracted millions in research funding, with projects totaling over €7.85M, and has received personal funding for her contributions to scientific research.

Publication Top Notes

📚 Raquel has authored 35 journal papers, 65 conference proceedings, and edited 4 books. She has also collaborated with over 100 international researchers, contributing to various Q1 journals such as Sensors. She organized a special issue in Sensors, highlighting her leadership in academic publishing.

“Development of Medical Microwave Imaging for Early Breast Cancer Detection” (2020), Sensors, cited by 85 articles. Link to article.

“Innovative Techniques in Microwave Imaging for Biomedical Applications” (2018), Biomedical Engineering Letters, cited by 45 articles. Link to article.

 

reyhaneh nassiri mansour | Regenerative medicine | Women Researcher Award

Published on by World Top Scientists

Dr. Reyhaneh nassiri mansour | regenerative medicine | Women Researcher Award

post doc, immunogenetic institue, Iran

Profile

Orcid

Short Bio 🌱

Reyhaneh Nassiri Mansour, born on June 5, 1986, in Tehran, Iran, is a clinical biochemist with a strong academic background and hands-on experience in stem cell research. With a focus on cancer research and regenerative medicine, she has contributed to significant advancements in biotechnology, particularly in the differentiation of stem cells into insulin-producing cells. Reyhaneh is an educator and researcher passionate about the interface of clinical biochemistry and molecular biology. She has published several peer-reviewed articles and presented her findings at international conferences.

Education 🎓

Reyhaneh completed her B.Sc. in General Biology from Islamic Azad University, North Tehran Branch, in 2008. She further pursued an M.Sc. in Clinical Biochemistry at Zanjan University of Medical Sciences (2012-2015), where her thesis focused on the expression levels of HIF-1 alpha gene in colorectal cancer stages. Her academic work under the supervision of Dr. Mojtaba Fathi fueled her interest in gene expression and stem cell therapy.

Experience 🧪

Reyhaneh has held multiple roles in academia and industry, contributing to her diverse skill set. She has worked as a research employee at Livogen Pharmed Co. and as a trainee at the Stem Cell Research Technology Center. With a deep understanding of laboratory techniques, including DNA extraction, real-time PCR, and stem cell culture, she has also taught General Biochemistry to B.Sc. students across various health disciplines at Zanjan University of Medical Sciences.

Research Interests 🔬

Her research interests span stem cell therapy, gene expression, and cancer research. She has focused on developing insulin-producing cells from human-induced pluripotent stem cells (hiPSCs) and exploring the role of hypoxia-inducible factor-1 alpha in cancer. Reyhaneh is also invested in using tissue engineering and scaffolds for regenerative medicine.

Publications Top Notes 📚

  1. Evaluation of hypoxia-inducible factor-1 alpha gene expression in colorectal cancer stages of Iranian patients. Mansour RN, et al. J Cancer Res Ther. 2016; 12(4):1313-1317. DOI: 10.4103/0973-1482.199542 (Cited by 15 articles)
  2. Generation of high-yield insulin producing cells from human-induced pluripotent stem cells on polyethersulfone nanofibrous scaffold. Mansour RN, et al. Artif Cells Nanomed Biotechnol. 2018. DOI: 10.1080/21691401.2018.1434663 (Cited by 32 articles)
  3. Collagen-coated electrospun polyethersulfone nanofibers improved insulin-producing cells’ differentiation potential of human induced pluripotent stem cells. Mansour RN, et al. Artif Cells Nanomed Biotechnol. 2018. DOI: 10.1080/21691401.2018.1508031 (Cited by 25 articles)
  4. Improved stem cell therapy of spinal cord injury using GDNF-overexpressed bone marrow stem cells in a rat model. Shahrezaei M, Mansour RN, et al. Biologicals. 2017. DOI: 10.1016/j.Biologicals.2017.08.009 (Cited by 18 articles)
  5. Improved osteogenic differentiation of human induced pluripotent stem cells cultured on poly vinylidene fluoride/collagen/platelet-rich plasma composite nanofibers. Mansour RN, et al. J Cell Physiol. 2019. DOI: 10.1002/jcp.29029 (Cited by 20 articles)
  6. Generation of insulin-producing cells from human-induced pluripotent stem cells on PLLA/PVA nanofiber scaffold. Mansour RN, et al. Artif Cells Nanomed Biotechnol. 2018. DOI: 10.1080/21691401.2018.1443466 (Cited by 28 articles)
  7. In vitro osteogenic differentiation potential of human induced pluripotent stem cells augmented on graphene oxide-modified nanofibers. Mansour RN, et al. Gene. 2019. DOI: 10.1016/j.gene.2019.02.028 (Cited by 16 articles)
  8. Glioblastoma: Exosome and microRNA as novel diagnostic biomarkers. Mansour RN, et al. Cancer Gene Ther. 2016. DOI: 10.1038/cgt.2016.48 (Cited by 30 articles)

Vuanghao Lim | Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Assoc Prof Dr. Vuanghao Lim | Pharmaceutical Science | Best Researcher Award

University Lecturer, USM, Malaysia

👨‍🔬 Lim Vuanghao is an Associate Professor at the Advanced Medical and Dental Institute, Universiti Sains Malaysia (USM). His extensive work in nanodrug delivery and green nano-synthesis has made him a recognized figure in the fields of pharmaceutical technology and metabolomics. He has held various leadership roles, including Head of the Integrative Medicine Cluster at USM. Lim’s research focuses on cutting-edge therapeutic strategies, emphasizing targeted drug delivery and the application of metabolomics in medical sciences.

Profile

Google Scholar

Strengths for the Award

Extensive Research Experience: Dr. Lim Vuanghao has a rich background in nanodrug delivery, green nano-synthesis, and metabolomics/chemometrics. His research contributions are well-documented across multiple platforms, including Web of Science, ORCID, Scopus, and Google Scholar.

Diverse Educational Background: Dr. Lim’s academic qualifications are impressive, with a Ph.D. in Pharmaceutical Technology, an M.Sc. in Pharmacy, a B.Sc. in Chemical Sciences, and additional qualifications in Acupuncture and Energy Medicine. This multidisciplinary education underpins his innovative research in nanotechnology and drug delivery systems.

Successful Grant Acquisition: Dr. Lim has secured significant research funding both internationally and nationally, demonstrating his capability to attract and manage research projects. These grants, such as those for breast cancer research and nanocomposite drug delivery systems, highlight his focus on high-impact research areas.

Graduate Supervision and Mentorship: He has successfully supervised several Ph.D. and Master’s students, which speaks to his role in developing the next generation of researchers. His supervision has led to the completion of innovative theses on topics such as green synthesis of nanoparticles and drug delivery systems.

Professional Recognition and Impact: Dr. Lim has been invited as a keynote speaker and research consultant on numerous occasions, indicating his expertise is well-recognized globally. His visiting fellowships and academic appointments in various countries further emphasize his international standing.

Professional and Community Service: His involvement in professional associations, such as the American Chemical Society and the Malaysian Institute of Chemistry, and his community service, particularly in environmental education and herbal medicine exploration, demonstrate a commitment to applying his expertise beyond academia.

Areas for Improvement

Publication Impact: While Dr. Lim’s research is broad and multidisciplinary, a focus on increasing the impact factor of his publications could strengthen his candidacy. Targeting top-tier journals and increasing citation metrics might further solidify his reputation as a leading researcher.

Research Diversity: Although Dr. Lim has a strong focus on nanotechnology and drug delivery, expanding his research into newer or emerging areas within pharmaceutical sciences could broaden his influence. Engaging in collaborative projects across different disciplines might also bring new perspectives and innovation.

Industry Collaboration: While Dr. Lim has some experience in consulting and contract research, increasing partnerships with the industry could enhance the practical application of his research. Establishing stronger ties with pharmaceutical companies or biotech firms could lead to commercialization opportunities.

Global Presence: Despite his international fellowships and visiting positions, further enhancing his global presence by leading international research consortia or hosting global conferences could elevate his profile further. Participation in global initiatives and publishing in international collaborations could be beneficial.

Education

🎓 Lim Vuanghao holds a PhD in Pharmaceutical Technology (2010) and an MSc in Pharmacy (2005) from Universiti Sains Malaysia. He also earned a B.Sc. (Hons) in Chemical Sciences from Universiti Putra Malaysia in 2002. Further enhancing his medical expertise, Lim completed a Doctor of Medicine in Acupuncture from the Indian Board of Alternative Medicines and a Diploma in Clinical Acupuncture and Energy Medicine from Xiamen University, China.

Experience

👨‍🏫 Lim Vuanghao has an extensive academic career, starting as a Research Assistant at the School of Pharmaceutical Sciences, USM, and later as a Lecturer at UCSI University. He has also served as the Head of the Integrative Medicine Cluster at USM, where he played a crucial role in advancing the institute’s research capabilities. Lim is also an active member of various grant evaluation panels and research committees.

Research Interest

🔬 Lim Vuanghao’s research interests revolve around nanodrug delivery systems, green nano-synthesis, and the application of metabolomics and chemometrics in medical research. His work aims to develop innovative therapeutic strategies, including targeted drug delivery systems for cancer treatment and the use of metabolomics to understand disease mechanisms better.

Awards

🏆 Lim Vuanghao has received numerous accolades, including an Academic Fellow Scheme (2023) at Universitas Airlangga, Indonesia, and a Senior Visiting Fellowship at Khesar Gyalpo University of Medical Sciences, Bhutan. His contributions to research have also been recognized through Visiting Professorships and Research Scholarships at various international institutions.

Publications Top Notes

📝 Selected Publications:

“Development of Quercetin PEGylated Nanodiamonds for Colon Cancer Inhibition” (2021, Universitas Airlangga). Link to Publication – Cited by 10 articles.

“Medicinal Herb of Clinacanthus Nutans for Nasopharyngeal Cancer: Biological Activity and Mechanism” (2021, Xinxiang Medical University). Link to Publication – Cited by 15 articles.

“Thiolated Alginate-PLGA Nanoparticles for Multi-Drug Resistant Breast Cancer” (2019, USM). Link to Publication – Cited by 20 articles.

Conclusion

Dr. Lim Vuanghao is a strong candidate for the “Best Researcher Award” due to his extensive research contributions, successful mentorship, and professional recognition. His work in nanodrug delivery and metabolomics is highly impactful, and his dedication to both academia and community service underscores his holistic approach to science. While there is room for growth in publication impact, research diversity, and industry collaboration, his current achievements position him as a leading figure in his field. His recognition as a global expert and his ability to secure substantial research funding further support his candidacy for this prestigious award.

Yan Ni | Pharmaceutical Research | Best Researcher Award

Published on by World Top Scientists

Dr. Yan Ni | Pharmaceutical Research | Best Researcher Award

Executive Director, Passage bio, United States

Profile

Google Scholar

Researcher Evaluation for “Best Researcher Award”

Strengths for the Award:

Extensive Expertise in Drug Development: Yan G. Ni, PhD, has over 15 years of experience in drug development, particularly in small molecules, biologics, and gene therapies. His work spans several critical therapeutic areas, including neurological and cardiovascular diseases, immune-oncology, hematology, and rare diseases. His contributions to IND/CTA submissions and regulatory interactions further highlight his deep involvement in the field.

Leadership in Translational Biomarker and Precision Medicine: Dr. Ni has demonstrated significant expertise in integrating preclinical and clinical biomarker strategies, contributing to the successful design and execution of biomarker-based clinical endpoints. His role in implementing PK and immunogenicity strategies across different phases of studies showcases his ability to bridge the gap between research and clinical application, a crucial factor in modern drug development.

Proven Management Skills: Dr. Ni’s management experience is evident in his ability to build and lead high-performing cross-functional teams. His leadership roles in international professional organizations like the AAPS and SAPA, as well as his track record of mentoring and inspiring others, underline his effectiveness as a leader in both scientific and organizational contexts.

High Scientific Productivity: With over 35 peer-reviewed publications, several book chapters, and six U.S. patents, Dr. Ni’s scientific output is substantial. His contributions to industry white papers and his role as an organizer and invited speaker at national and international conferences further affirm his thought leadership in the field.

Recognition and Awards: Dr. Ni has received numerous prestigious awards, such as the Passage Bio High Impact Award, Regeneron High Impact Award, AAPS Excellence in Ligand Binding Assays Award, and Merck Award of Excellence. These accolades reflect his high-impact contributions to the field and recognition by peers and industry leaders.

Areas for Improvement:

Broader Impact Beyond Specialized Fields: While Dr. Ni’s expertise is well-recognized within specialized areas such as biomarkers, precision medicine, and drug development, expanding his influence into broader, interdisciplinary research domains could enhance his candidacy for a “Best Researcher Award.” For example, engaging in research that impacts public health or other critical global issues might increase his visibility and impact.

Further Innovation in Emerging Therapeutic Areas: While Dr. Ni has made significant contributions to established therapeutic areas, greater involvement in cutting-edge fields such as artificial intelligence in drug discovery or personalized medicine could position him as a pioneer in these rapidly evolving areas.

Enhanced Collaboration with Global Initiatives: Although Dr. Ni has demonstrated leadership in professional organizations and consortia, expanding his collaborative efforts to include global health initiatives or large-scale, multi-national research projects could further amplify his contributions and align with broader global research priorities.

Professional Experience

Passage Bio, Philadelphia, PA
Executive Director, Biomarkers and Precision Medicine
2021-Present
Senior Director, Head of Biomarkers and Precision Medicine
2020-2021

Built and led a high-performing team responsible for driving clinical biomarker, PK/biodistribution, immunogenicity studies, and supporting clinical operations.

Developed and implemented biomarker, PK, and immunogenicity strategies to inform decision-making for neurodegenerative disease portfolios.

Led biomarker and precision medicine support for IND/CTA submissions and global regulatory interactions.

Oversaw partnerships with external CROs and laboratories, and collaborated with Clinical Study Teams on biomarker inclusion in clinical portfolios.

Regeneron, Tarrytown, NY
Associate Director, Precision Medicine, Early Clinical Development & Experimental Sciences
2016-2020

Designed and implemented biomarker strategies to support dose selection and efficacy readings for complement-mediated rare diseases.

Provided strategic leadership for discovery and early cardiovascular programs, influencing biomarker-driven decisions on target validation, disease indication selection, and patient stratification.

Led multiple biomarker-focused natural history studies with academic and clinical centers.

Bristol Myers Squibb, Princeton, NJ
Senior Research Investigator II, R&D/PD/ABD/BAS-Biologics
2012-2016

Supported biomarker bioanalytical strategy implementation for immuno-oncology, immunology, and cardiovascular diseases.

Supervised biomarker method development and validation by internal staff and CROs.

Provided strategic and technical input on biomarker bioanalytical plans, resources, and timelines for FIH and PoC studies.

Merck & Co., Inc., Rahway, NJ
Senior Research Scientist, Cardiovascular Franchise Atherosclerosis Group
2007-2011

Led the development of a 2nd generation fully human monoclonal antibody for PCSK9.

Established ELISA-based pharmacodynamics and target engagement biomarker assays.

University of Texas Southwestern Medical Center, Dallas, TX
Research Assistant Professor, Internal Medicine Department, Cardiology
2001-2007
Research Scientist, Department of Pharmacology & Alliance for Cellular Signaling
2001-2007

Conducted research on cardiac hypertrophy, heart failure, and aging, focusing on Akt and FOXO transcriptional factors.

Education and Training

Persuasive Leadership Development: Wharton Business School, University of Pennsylvania

Postdoctoral Training: Yale University, under Professors Gary Rudnick and Eric Nestler

Ph.D. in Neuroscience: University of California, Irvine, under Professor Ricardo Miledi

M.S. in Pharmacology: Institute of Basic Medical Sciences, Beijing, China

B.S. in Biochemistry: Anhui University, Hefei, China

Professional Honors

Passage Bio High Impact Award (2021)

Regeneron High Impact Award and Multiple STAR Awards (2016-2020)

AAPS Excellence in Ligand Binding Assays Award (2015)

BMS R&D ROC Award and Multiple STAR Awards (2014)

Merck Award of Excellence (2007, 2008, 2009)

Professional Affiliations

American Association of Pharmaceutical Scientists (AAPS):

Founding Member and Chair of the Biomarkers and Translational Medicine Community

Founding Member and Chair of the Gene and Cell Therapeutic Products Community

Sino-American Pharmaceutical Professionals Association (SAPA):

Director for Public Outreach and Executive Committee Member

Publications

Yang, J., Mapelli, C., Wang, Z., et al. (2022). An Optimized Agonist Peptide of Protease-activated Receptor 4 and its Use in a Platelet Aggregation Assay to Monitor the Pharmacodynamic Effects of PAR4 Antagonists. Platelets. DOI: 10.1080/09537104.2022.2053091

Hays, A., Amaravadi, L., Fernandez-Metzler, C., et al. (2022). Is Incurred Sample Reanalysis (ISR) applicable in Biomarker Assays? AAPS J, 24:65. DOI: 10.1208/s12248-022-00708-y

Ni, Y.G., King, L., Fernández-Metzler, C. (2022). Recent Progress in Biomarker Bioanalysis and Target Engagement in Bioanalytical Aspects in Biological Therapeutics. ISBN: 9781119523215. Edited by Xu, X. & Xu, W.

Conclusion:

Dr. Yan G. Ni, PhD, is an outstanding candidate for the “Best Researcher Award” based on his extensive contributions to drug development, biomarker research, and precision medicine. His leadership, scientific productivity, and recognition by peers make him a strong contender for the award. However, expanding his research impact into broader and more emerging fields could further strengthen his profile for this prestigious recognition.

RAJWINDER KAUR | MEDICINAL CHEMISTRY | Best Researcher Award

Published on by World Top Scientists

Dr. RAJWINDER KAUR | MEDICINAL CHEMISTRY | Best Researcher Award

PROFESSOR, CHITKARA UNIVERSITY, India

Dr. Rajwinder Kaur is an esteemed professor and researcher with over 16 years of experience in pharmaceutical education and research. She currently holds the position of Assistant Dean for the PharmD Program at Chitkara University, Rajpura. Her career is marked by significant contributions to the field of pharmaceutical chemistry, focusing on drug design and development. Dr. Kaur has received numerous awards and honors for her dedication and excellence in the field, including the Young Scientist Award and the Best Teacher Award.

Education 🎓

Dr. Rajwinder Kaur has an extensive academic background in pharmaceutical sciences. She completed her B. Pharm with distinction from A.S.B.A.S.J.S.M. College of Pharmacy in 2004 and her M. Pharm from Rajiv Academy for Pharmacy in 2007. She earned her Ph.D. in Pharmaceutical Chemistry from Panjab University, Chandigarh in 2014. Additionally, she holds multiple postgraduate diplomas, including in Clinical Trial, Research & Administration, and Guidance and Counselling.

Professional Experience 🏢

Dr. Kaur’s professional journey spans various prestigious institutions. She began as a lecturer at Polytechnic Institute for Women, Ropar, and later joined Panjab University as a Project Fellow and CSIR-SRF. She has also served as a Women Scientist under the DST-WOS(A) scheme. Her recent roles include Assistant Professor at Chandigarh University, and Associate Professor, Professor, and Assistant Dean at Chitkara University.

Research Interests 🔬

Dr. Kaur’s research interests lie in computer-aided drug design and the discovery of new chemical entities. Her focus areas include the development of novel adenosine receptor ligands, anti-inflammatory agents, antiasthmatics, and neuroprotective compounds. She also explores natural products for treating diseases like dengue and cerebral ischemic injury.

Awards 🏆

Dr. Kaur has been recognized with several prestigious awards, including:

  • Young Scientist Award (Women in Pharmaceutical Sciences) at Chitkara University in 2023
  • Best Teacher Award by Chandigarh University in 2016
  • Dr. Harpal Singh Buttar and Harinder Kaur Buttar Young Scientist Award in 2013
  • DST Women Scientist (WOS-A) by the Department of Science and Technology, India

Profile 🌐

Google Scholar Profile: Dr. Rajwinder Kaur

Publications Top Notes 📚

Target protein degradation by protacs: A budding cancer treatment strategy. Pharmacology & Therapeutics, 2023. DOI: 10.1016/j.pharmthera.2023.108525

Evolving Advances in the Cosmetic Use of Probiotics and Postbiotics: Health, Regulatory and Marketing Aspects. Curr Pharm Biotechnol, 2023. DOI: 10.2174/1389201024666230703115732

Combating Microbial Infections Using Metal-Based Nanoparticles as Potential Therapeutic Alternatives. Antibiotics, 2023. DOI: 10.3390/antibiotics12050909

Antibiotics in Paediatrics: A Boon or a Bane? Anti-Infective Agents, 2023, 21(2), 1-17.

Synthesis and Pharmacological Evaluation of Promising Coumarin Methyl ester/di/tri/terta Peptide Derivatives. ECS Transactions, 2022, 107(1), 6747–6761.

In Silico Evaluation of Reserpine as Potential Anti-Candidal Agent. J. Pharm. Tech. Res. Management, 2021, 9(1), 1–5.

Importance of Pharmacovigilance in Ayurveda. J. Pharm. Tech. Res. Management, 2021, 9(2), 87–97.

Targeting natural products against SARS-CoV-2. Environmental Science and Pollution Research, 2022, 29(28), 42404–42432.